Nahid Einollahi

Nahid Einollahi

Auto-generated profile, based on publicly available information

Nahid Einollahi

Department of Clinical Laboratory Sciences, Faculty of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Peptides
Verified
Journal Article
Closed access
ZGZafar Gholinejad
Zafar Gholinejad
NKNejat Kheiripour
Nejat Kheiripour
MNMitra Nourbakhsh
Mitra Nourbakhsh
DIDavod Ilbeigi
Davod Ilbeigi
KBKiarash Behroozfar
Kiarash Behroozfar
NENahid Einollahi
Nahid Einollahi

1 May 2003 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
JKJacqueline Keyhani
Jacqueline Keyhani
EKEzzatollah Keyhani
Ezzatollah Keyhani
NENahid Einollahi
Nahid Einollahi
DMDariush Minai-Tehrani
Dariush Minai-Tehrani
SZSekineh Zarchipour
Sekineh Zarchipour

1 January 2016 in Blood Coagulation & Fibrinolysis
Verified
Journal Article
Closed access
MNMajid Naderi
Majid Naderi
SRSamira Esmaeili Reykande
Samira Esmaeili Reykande
Akbar DorgalalehAkbar Dorgalaleh
Akbar Dorgalaleh
SAShaban Alizadeh
Shaban Alizadeh
STShadi Tabibian
Shadi Tabibian
EMEbrahim Miri-Moghaddam
Ebrahim Miri-Moghaddam
Factor XIII deficiency (FXIIID) is an extremely rare bleeding disorder with a prevalence of 1 in 3 million in the general population. Compared to its global incidence, it has the greatest prevalence in Sistan and Baluchistan Province in the southeast of Iran. The high incidence of FXIIID in this region causes a high rate of morbidity and mortality among the affected individuals because of life-threatening episodes such as central nervous system (CNS) bleeding, umbilical cord bleeding, as well as miscarriage. CNS bleeding leads to a considerable number of neurological and behavioral complications. Therefore, we have designed an established prenatal diagnosis (PND) program to prevent the increasing incidence of life-threatening bleeding episodes and related complications among neonates with congenital FXIIID. This study was conducted from September 2013 to August 2014. A consent form was signed by the parents. Fetal sampling was done via abdominal chorionic villus sampling passage under local anesthesia and ultrasonic guidance within the first trimester of pregnancy. Fetal DNA was extracted, and PCR-restriction fragment length polymorphism was performed for the only reported mutation of FXIII (Trp187Arg) in the southeast of Iran. During the period of study, PND was performed on eight fetuses. Six fetuses were offspring of parental consanguineous marriages, and all of them had a positive family history of FXIIID. Seven out of the eight fetuses had a family member with CNS bleeding due to FXIIID. Four fetuses had a FXIIID-related death. One of the fetuses bore homozygous Trp187Arg mutation, whereas six were heterozygous, and one of the mothers gave birth to an unaffected fetus. To the best of our knowledge, PND is a possible solution to control high incidence of life-threatening episodes of FXIIID in southeast Iran.

15 April 2005 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
JKJacqueline Keyhani
Jacqueline Keyhani
EKEzzatollah Keyhani
Ezzatollah Keyhani
SZSekineh Zarchipour
Sekineh Zarchipour
HTHossein Tayefi-Nasrabadi
Hossein Tayefi-Nasrabadi
NENahid Einollahi
Nahid Einollahi

1 July 2011
Verified
Journal Article
Closed access
MHMohammad taher Hojjati
Mohammad taher Hojjati
NENahid Einollahi
Nahid Einollahi
FNFariba Nabatchian
Fariba Nabatchian
APAli Akbar Pourfathollah
Ali Akbar Pourfathollah
MMMohammad Reza Mahdavi
Mohammad Reza Mahdavi

1 March 2017
Verified
Journal Article
Open access
DIDavod Ilbeigi
Davod Ilbeigi
MNMitra Nourbakhsh
Mitra Nourbakhsh
SKShahnaz Khaghani
Shahnaz Khaghani
NENahid Einollahi
Nahid Einollahi
NKNejat Kheiripour
Nejat Kheiripour
MSMostafa Saberian
Mostafa Saberian
Objective: There is a positive correlation between higher serum phytoestrogen concentrations and lower risk of breast cancer. The activation of telomerase is crucial for the growth of cancer cells; therefore, the aim of this study was to examine the effects of enterolactone (ENL) and enterodiol (END) on this enzyme. Materials and Methods: In this experimental study, we performed the viability assay to determine the effects of different concentrations of ENL and END on cell viability, and the effective concentrations of these two compounds on cell growth. We used western blot analysis to evaluate human telomerase reverse transcriptase catalytic subunit (hTERT) expression and polymerase chain reaction (PCR)-ELISA based on the telomeric repeat amplification protocol (TRAP) assay for telomerase activity. Results: Both ENL and END, at 100 mu M concentrations, significantly (P<0.05) reduced cell viability. However, only the 100 mu M concentration of ENL significantly (P<0.05) decreased hTERT protein levels and telomerase activity. Lower concentrations of ENL did not have any significant effects on telomerase activity and hTERT protein levels. Conclusion: High concentration of ENL decreased the viability of MCF-7 breast cancer cells and inhibited the expression and activity of telomerase in these cells. Although END could reduce breast cancer cell viability, it did not have any effect on telomerase expression and activity.